NCT01792206View on ClinicalTrials.gov

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2012

Study Completion Date

February 28, 2013

Conditions
Type 2 DiabetesChronic Kidney Disease
Interventions
DRUG

Zemplar

Zemplar 1 mcg or placebo to be taken once daily with breakfast for 3 months

DRUG

Placebo

Zemplar 1 mcg or placebo to be taken once daily with breakfast for 3 months

Trial Locations (4)

30303

Emory University, Atlanta

68105

Omaha VA Medical Center, Omaha

70112

Tulane University, New Orleans

02215

Joslin Diabetes Clinic, Inc., Boston

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Scott and White Hospital & Clinic

OTHER

NCT01792206 - Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease | Biotech Hunter | Biotech Hunter